79.5 F
New York
Sunday, June 20, 2021

Teva [NYSE: TEVA] Gets EU Authorization for Seffalair and BroPair Spiromax

Must read

Maiar Crypto App Now Supports Bitcoin

Maiar brings an exciting opportunity for Bitcoin proponents as Elrond-powered mobile app Maiar can now store and transact with Bitcoin. Maiar is a non-custodial...

Kadant [NYSE: KAI] Announces Acquisition of Joh. Clouth

Kadant Inc. disclosed Thursday that it has decided to purchase Joh. Clouth GmbH & Co. KG and its affiliates (Clouth). The firm has...

VEON [NASDAQ: VEON] Announces Acquisition of AdTech in Russia

VEON Ltd disclosed that it has purchased a majority stake in OTM which is a technology platform for the automation and planning of...

MicroStrategy Decides to Sell $1B Stock With Plans To Buy More Bitcoin With Profit

Shares of MicroStrategy Incorporated skyrocketed 5.36% on Wednesday after the firm disclosed that it has decided to dump $1 billion worth of its...

Teva Pharmaceutical Industries Limited [NYSE: TEVA] disclosed that it has got EU Marketing Authorization for Seffalair Spiromax and its duplicate BroPair Spiromax. This is the greatest accomplishment for the firm. It will deliver new cure options to healthcare experts who aid people living with conditions such as asthma.

Furthermore, the firm has committted to empower the victims who has been living with asthma to mange their condition. At the same time, it also provide cost-effective cure to healthcare systems.

Launch of Seffalair and BroPair Spiromax

Teva Pharmaceutical disclosed that it has scheduled the rollout in Spain, Portugal, UK, and Switzerland. Since the rollout of DuoResp Spiromax, the Spiromax inhaler has been well supported by healthcare experts and sufferers. Additionally, Inhaler technique and therapy devotion are important factors in enhancing results for asthma sufferers.

About Seffalair and BroPair Spiromax

Seffalair Spiromax and BroPair Spiromax are designated as a routine therapy for asthma in grown-ups and youngsters at the age of 12 years and older not appropriately controlled with inhaled corticosteroids and ‘as required’ inhaled short-acting β2 agonists.

More articles

Latest article

Thailand SEC Forbids Crypto Exchanges from Listing Meme Tokens, NFTs, and More

Thailand SEC has made a new decision that forbids crypto exchanges to list meme tokens, NFTs, and many more. The decision to ban certain...

China’s Cryptocurrency Mining Crackdown Appears to be Widening

The cryptocurrency mining crackdown of China is continuously increasing. It has been seen that government departments in the province of Yunnan are gearing up...

Accenture [NYSE: ACN] and Salesforce to Aid ISDI to Reduce its Environmental Impact

Accenture plc and Salesforce have partnered with ISDI to provide aid to the Salesforce-authorized global coaching organization. The firms will evaluate their carbon...

Iconix Brand [NASDAQ: ICON] to be Acquired by Iconix Acquisition Corp

Iconix Brand Group, Inc. disclosed that it has inked an agreement and plan of merger with Iconix Acquisition Corp. Iconix Brand Group is...

Binance Cryptocurrency Exchange to Launch a New NFT Platform

The Binance cryptocurrency exchange will be introducing a new on-chain NFT platform called "Featured by Binance". Cryptocurrency exchange Binance is joining the race of...

El Salvador Passes Bill to Accept Bitcoin as Legal Tender

EI Salvador has become the first country in Central America to pass the bill to accept Bitcoin as legal tender. It has been disclosed...

Gaming Platform Xaya Teams Up with Popular Ethereum Scaling Solution Polygon

Blockchain Gaming platform Xaya has joined hands with popular Ethereum scaling solution Polygon. Xaya has partnered with Polygon to improve the scalability of its...

Why CynergisTek [CTEK] is Skyrocketing Today?

CynergisTek, Inc. skyrocketed 24.73% during the trading session of Wednesday. The positive performance of the firm indicated the positive sentiments of the investors...